Stock Information

NASDAQ: ONCY

TSX: ONC

Analyst Coverage

Firm Analyst
Canaccord Genuity John Newman
Cantor Fitzgerald Louise Chen
H.C. Wainwright Patrick Trucchio
JonesTrading Soumit Roy
Leede Jones Gable Inc. Doug Loe
Maxim Group Jason McCarthy
RBC Capital Markets Douglas Miehm
Raymond James Michael Freeman

Oncolytics Biotech, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Oncolytics Biotech, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Oncolytics Biotech, Inc. or its management. Oncolytics Biotech, Inc. does not by its reference above or distribution, imply its endorsement of or concurrence with such information, conclusions or recommendations.

Investor Relations Contact

Jon Patton
Director of Investor Relations & Communication
Email: jpatton@oncolytics.ca

Email Alerts Sign-Up